Gabriele Bignante
Rush University Medical Center, Ospedale San Luigi Gonzaga, University of Turin, Rush University
Papers
14
Total Citations
131
H-Index
7
About
Gabriele Bignante is a leading urologic surgeon and researcher at the forefront of minimally invasive oncology, with a primary focus on advancing single-port robotic surgery for urologic cancers. His work has fundamentally reshaped surgical approaches for prostate and kidney cancers, particularly in frail and surgically complex patients. Bignante’s major contributions include pioneering comparative analyses demonstrating that extraperitoneal single-port robot-assisted radical prostatectomy and retroperitoneal single-port partial nephrectomy offer superior perioperative outcomes in patients with hostile abdomens or significant comorbidities. He has also provided critical long-term evidence through a ten-year follow-up of a randomized controlled trial comparing laparoscopic and robot-assisted radical prostatectomy, establishing benchmarks for functional and oncological durability. His research on single-port transvesical simple prostatectomy for benign prostatic hyperplasia has further expanded the applications of this technology. With over 100 citations across his most influential works, including a highly cited 2024 review on recent advances in robotic-assisted urologic surgery, Bignante is a key contributor to the ROBUUST collaborative study on upper tract urothelial carcinoma. His work consistently emphasizes reducing invasiveness, improving recovery, and tailoring surgical strategies to patient-specific risk profiles.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10